Richmond Pharmacology is excited to join the PNS Congress 2026 in Maastricht, The Netherlands, on 12- 15 June 2026.
Bringing together global leaders in peripheral nerve research and clinical care, this meeting serves as a key platform for advancing understanding of neuromuscular disorders, accelerating therapeutic innovation, and fostering collaboration between academia, industry, and patient organizations.
Representing Richmond Pharmacology
Dr Jörg Taubel, Chief Executive Officer
We look forward to connecting with attendees to discuss Richmond’s expertise in:
Connect With Us
If you are attending the PNS Annual Meeting 2026 and would like to explore partnership or development opportunities email us at:
📧 fasteranswers@richmondpharmacology.com